Compare RXO, Inc. with Similar Stocks
Stock DNA
Software Products
USD 2,549 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.29
-0.13%
1.61
Total Returns (Price + Dividend) 
RXO, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

RXO, Inc. Hits Day Low of $12.16 Amid Price Pressure
RXO, Inc., a small-cap software company, saw its stock decline significantly today, reflecting ongoing performance challenges. Despite a high return on capital employed, the company reported a substantial net loss in the first half of the year. Its long-term performance has lagged behind the S&P 500.
Read full news article
RXO, Inc. Hits 52-Week Low at USD 12.16 Amidst Significant Decline
RXO, Inc., a small-cap software company, has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company has a market capitalization of approximately USD 2,793 million and faces challenges, including negative return on equity and EBITDA, despite high management efficiency.
Read full news article Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 67 Schemes (37.25%)
Held by 116 Foreign Institutions (30.08%)
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 0.14% vs -0.98% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -55.56% vs 70.97% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 15.86% vs -18.12% in Dec 2023
YoY Growth in year ended Dec 2024 is -7,350.00% vs -95.65% in Dec 2023






